Inventor
GLASKY ALVIN J
US19 patents
⚠️ This page may combine multiple inventors who share the name “GLASKY ALVIN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEOTHERAPEUTICS INC
7 patentsUS6630478B2Oct 7, 2003
Methods for treatment of drug-induced peripheral neuropathy
NEOTHERAPEUTICS INC59 citations94
US6297226B1Oct 2, 2001
Synthesis and methods of use of 9-substituted guanine derivatives
NEOTHERAPEUTICS INC27 citations92
US6338963B1Jan 15, 2002
Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
NEOTHERAPEUTICS INC20 citations91
US6630490B2Oct 7, 2003
Methods for treatment of disease-induced peripheral neuropathy and related conditions
NEOTHERAPEUTICS INC32 citations90
US6303617B1Oct 16, 2001
Serotonin-like 9-substituted hypoxanthine and methods of use
NEOTHERAPEUTICS INC4 citations62
US6288069B1Sep 11, 2001
Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
NEOTHERAPEUTICS INC4 citations62
US6407237B1Jun 18, 2002
Crystal forms of 9-substituted hypoxanthine derivatives
NEOTHERAPEUTICS INC0 citations51
SPECTRUM PHARMACEUTICALS INC
5 patentsUS6770638B2Aug 3, 2004
Tetrahydroindolone and purine derivatives linked to arylpiperazines
SPECTRUM PHARMACEUTICALS INC22 citations92
US6759427B2Jul 6, 2004
Synthesis and methods of use of tetrahydroindolone analogues and derivatives
SPECTRUM PHARMACEUTICALS INC16 citations92
US6982269B2Jan 3, 2006
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
SPECTRUM PHARMACEUTICALS INC16 citations90
US8734818B2May 27, 2014
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
SPECTRUM PHARMACEUTICALS INC1 citations62
US8377456B2Feb 19, 2013
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
SPECTRUM PHARMACEUTICALS INC3 citations62
(unassigned)
4 patentsUS5447939ASep 5, 1995
Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
74 citations95
US6027936AFeb 22, 2000
Carbon monoxide dependent guanyly cyclase modifiers and methods of use
34 citations91
US5801184ASep 1, 1998
Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
34 citations91
US6350752B1Feb 26, 2002
Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
16 citations83
GLASKY ALVIN J
2 patentsUS5091432AFeb 25, 1992
9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
GLASKY ALVIN J48 citations94
US8063233B2Nov 22, 2011
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
GLASKY ALVIN J5 citations71